Show simple item record

dc.contributor.authorThewes, B
dc.contributor.authorKaal, SEJ
dc.contributor.authorCusters, JAE
dc.contributor.authorManten-Horst, E
dc.contributor.authorJansen, R
dc.contributor.authorServaes, P
dc.contributor.authorvan der Graaf, WTA
dc.contributor.authorPrins, JB
dc.contributor.authorHusson, O
dc.date.accessioned2017-11-15T12:10:18Z
dc.date.issued2018-05
dc.identifier.citationSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, 26 (5), pp. 1479 - 1487
dc.identifier.issn0941-4355
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/908
dc.identifier.eissn1433-7339
dc.identifier.doi10.1007/s00520-017-3975-2
dc.description.abstractOBJECTIVE:High fear of cancer recurrence (FCR) is a frequently reported problem among cancer patients. Previous research has shown that younger age is associated with higher levels of FCR. However, little attention has been given to date about how FCR manifests itself among adolescent and young adult (AYA) cancer patients. This study explores the prevalence, correlates of high FCR, and its association with HRQoL in cancer patients in their late adolescence or young adulthood. METHODS:Seventy-three AYA cancer patients, aged 18-35 years at diagnosis, consulted the AYA team of the Radboud University Medical Center completed questionnaires including the Cancer Worry Scale (CWS), Quality of Life-Cancer Survivors (QOL-CS), and Hospital Anxiety and Depression Scale (HADS). Sociodemographic and medical data was collected by self-reported questionnaire. RESULTS:Forty-five participants experienced high FCR (62%), which was higher than the 31-52% reported in previous studies among mixed adult cancer patient samples. Sociodemographic and medical variables were not associated with levels of FCR. High FCR was significantly associated with lower levels of social and psychological functioning and overall HRQoL and higher levels of anxiety and psychological distress. CONCLUSION:Results illustrate that FCR is a significant problem among AYA cancer patients consulting an AYA team, with participants reporting higher levels of FCR than cancer patients of mixed ages. Health care providers should pay specific attention to this problem by screening and the provision of appropriate psychosocial care when needed.
dc.formatPrint-Electronic
dc.format.extent1479 - 1487
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0
dc.subjectHumans
dc.subjectNeoplasm Recurrence, Local
dc.subjectPrevalence
dc.subjectAnxiety
dc.subjectFear
dc.subjectAnxiety Disorders
dc.subjectPhobic Disorders
dc.subjectQuality of Life
dc.subjectAdolescent
dc.subjectAdult
dc.subjectMiddle Aged
dc.subjectReferral and Consultation
dc.subjectFemale
dc.subjectMale
dc.subjectYoung Adult
dc.subjectSpecialization
dc.subjectCancer Survivors
dc.titlePrevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult (AYA) cancer service.
dc.typeJournal Article
dcterms.dateAccepted2017-11-13
rioxxterms.versionofrecord10.1007/s00520-017-3975-2
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc/4.0
rioxxterms.licenseref.startdate2018-05
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
pubs.issue5
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma
pubs.publication-statusPublished
pubs.volume26
pubs.embargo.termsNo embargo
icr.researchteamClinical and Translational Sarcomaen_US
dc.contributor.icrauthorvan der Graaf, Wilhelminaen
dc.contributor.icrauthorHusson, Olgaen


Files in this item

Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc/4.0